Global Bicalutamide Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 163715
  • calendar_today Published On: Jun, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

According to our latest study, the global Bicalutamide Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Bicalutamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Bicalutamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Bicalutamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Bicalutamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Bicalutamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Bicalutamide Tablets

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Bicalutamide Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Fosun Pharma, HISUN, FORWARD and CordenPharma. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Bicalutamide Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

14 Tablets Per Box

28 Tablets Per Box

Market segment by Application

Hospital

Clinic

Major players covered

AstraZeneca

Fosun Pharma

HISUN

FORWARD

CordenPharma

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Bicalutamide Tablets product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Bicalutamide Tablets, with price, sales, revenue and global market share of Bicalutamide Tablets from 2018 to 2023.

Chapter 3, the Bicalutamide Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Bicalutamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Bicalutamide Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Bicalutamide Tablets.

Chapter 14 and 15, to describe Bicalutamide Tablets sales channel, distributors, customers, research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Bicalutamide Tablets

1.2 Market Estimation Caveats and Base Year

1.3 Market Analysis by Type

1.3.1 Overview: Global Bicalutamide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029

1.3.2 14 Tablets Per Box

1.3.3 28 Tablets Per Box

1.4 Market Analysis by Application

1.4.1 Overview: Global Bicalutamide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029

1.4.2 Hospital

1.4.3 Clinic

1.5 Global Bicalutamide Tablets Market Size & Forecast

1.5.1 Global Bicalutamide Tablets Consumption Value (2018 & 2022 & 2029)

1.5.2 Global Bicalutamide Tablets Sales Quantity (2018-2029)

1.5.3 Global Bicalutamide Tablets Average Price (2018-2029)

2 Manufacturers Profiles

2.1 AstraZeneca

2.1.1 AstraZeneca Details

2.1.2 AstraZeneca Major Business

2.1.3 AstraZeneca Bicalutamide Tablets Product and Services

2.1.4 AstraZeneca Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 AstraZeneca Recent Developments/Updates

2.2 Fosun Pharma

2.2.1 Fosun Pharma Details

2.2.2 Fosun Pharma Major Business

2.2.3 Fosun Pharma Bicalutamide Tablets Product and Services

2.2.4 Fosun Pharma Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Fosun Pharma Recent Developments/Updates

2.3 HISUN

2.3.1 HISUN Details

2.3.2 HISUN Major Business

2.3.3 HISUN Bicalutamide Tablets Product and Services

2.3.4 HISUN Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 HISUN Recent Developments/Updates

2.4 FORWARD

2.4.1 FORWARD Details

2.4.2 FORWARD Major Business

2.4.3 FORWARD Bicalutamide Tablets Product and Services

2.4.4 FORWARD Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 FORWARD Recent Developments/Updates

2.5 CordenPharma

2.5.1 CordenPharma Details

2.5.2 CordenPharma Major Business

2.5.3 CordenPharma Bicalutamide Tablets Product and Services

2.5.4 CordenPharma Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 CordenPharma Recent Developments/Updates

3 Competitive Environment: Bicalutamide Tablets by Manufacturer

3.1 Global Bicalutamide Tablets Sales Quantity by Manufacturer (2018-2023)

3.2 Global Bicalutamide Tablets Revenue by Manufacturer (2018-2023)

3.3 Global Bicalutamide Tablets Average Price by Manufacturer (2018-2023)

3.4 Market Share Analysis (2022)

3.4.1 Producer Shipments of Bicalutamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022

3.4.2 Top 3 Bicalutamide Tablets Manufacturer Market Share in 2022

3.4.2 Top 6 Bicalutamide Tablets Manufacturer Market Share in 2022

3.5 Bicalutamide Tablets Market: Overall Company Footprint Analysis

3.5.1 Bicalutamide Tablets Market: Region Footprint

3.5.2 Bicalutamide Tablets Market: Company Product Type Footprint

3.5.3 Bicalutamide Tablets Market: Company Product Application Footprint

3.6 New Market Entrants and Barriers to Market Entry

3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Bicalutamide Tablets Market Size by Region

4.1.1 Global Bicalutamide Tablets Sales Quantity by Region (2018-2029)

4.1.2 Global Bicalutamide Tablets Consumption Value by Region (2018-2029)

4.1.3 Global Bicalutamide Tablets Average Price by Region (2018-2029)

4.2 North America Bicalutamide Tablets Consumption Value (2018-2029)

4.3 Europe Bicalutamide Tablets Consumption Value (2018-2029)

4.4 Asia-Pacific Bicalutamide Tablets Consumption Value (2018-2029)

4.5 South America Bicalutamide Tablets Consumption Value (2018-2029)

4.6 Middle East and Africa Bicalutamide Tablets Consumption Value (2018-2029)

5 Market Segment by Type

5.1 Global Bicalutamide Tablets Sales Quantity by Type (2018-2029)

5.2 Global Bicalutamide Tablets Consumption Value by Type (2018-2029)

5.3 Global Bicalutamide Tablets Average Price by Type (2018-2029)

6 Market Segment by Application

6.1 Global Bicalutamide Tablets Sales Quantity by Application (2018-2029)

6.2 Global Bicalutamide Tablets Consumption Value by Application (2018-2029)

6.3 Global Bicalutamide Tablets Average Price by Application (2018-2029)

7 North America

7.1 North America Bicalutamide Tablets Sales Quantity by Type (2018-2029)

7.2 North America Bicalutamide Tablets Sales Quantity by Application (2018-2029)

7.3 North America Bicalutamide Tablets Market Size by Country

7.3.1 North America Bicalutamide Tablets Sales Quantity by Country (2018-2029)

7.3.2 North America Bicalutamide Tablets Consumption Value by Country (2018-2029)

7.3.3 United States Market Size and Forecast (2018-2029)

7.3.4 Canada Market Size and Forecast (2018-2029)

7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

8.1 Europe Bicalutamide Tablets Sales Quantity by Type (2018-2029)

8.2 Europe Bicalutamide Tablets Sales Quantity by Application (2018-2029)

8.3 Europe Bicalutamide Tablets Market Size by Country

8.3.1 Europe Bicalutamide Tablets Sales Quantity by Country (2018-2029)

8.3.2 Europe Bicalutamide Tablets Consumption Value by Country (2018-2029)

8.3.3 Germany Market Size and Forecast (2018-2029)

8.3.4 France Market Size and Forecast (2018-2029)

8.3.5 United Kingdom Market Size and Forecast (2018-2029)

8.3.6 Russia Market Size and Forecast (2018-2029)

8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

9.1 Asia-Pacific Bicalutamide Tablets Sales Quantity by Type (2018-2029)

9.2 Asia-Pacific Bicalutamide Tablets Sales Quantity by Application (2018-2029)

9.3 Asia-Pacific Bicalutamide Tablets Market Size by Region

9.3.1 Asia-Pacific Bicalutamide Tablets Sales Quantity by Region (2018-2029)

9.3.2 Asia-Pacific Bicalutamide Tablets Consumption Value by Region (2018-2029)

9.3.3 China Market Size and Forecast (2018-2029)

9.3.4 Japan Market Size and Forecast (2018-2029)

9.3.5 Korea Market Size and Forecast (2018-2029)

9.3.6 India Market Size and Forecast (2018-2029)

9.3.7 Southeast Asia Market Size and Forecast (2018-2029)

9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

10.1 South America Bicalutamide Tablets Sales Quantity by Type (2018-2029)

10.2 South America Bicalutamide Tablets Sales Quantity by Application (2018-2029)

10.3 South America Bicalutamide Tablets Market Size by Country

10.3.1 South America Bicalutamide Tablets Sales Quantity by Country (2018-2029)

10.3.2 South America Bicalutamide Tablets Consumption Value by Country (2018-2029)

10.3.3 Brazil Market Size and Forecast (2018-2029)

10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

11.1 Middle East & Africa Bicalutamide Tablets Sales Quantity by Type (2018-2029)

11.2 Middle East & Africa Bicalutamide Tablets Sales Quantity by Application (2018-2029)

11.3 Middle East & Africa Bicalutamide Tablets Market Size by Country

11.3.1 Middle East & Africa Bicalutamide Tablets Sales Quantity by Country (2018-2029)

11.3.2 Middle East & Africa Bicalutamide Tablets Consumption Value by Country (2018-2029)

11.3.3 Turkey Market Size and Forecast (2018-2029)

11.3.4 Egypt Market Size and Forecast (2018-2029)

11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)

11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

12.1 Bicalutamide Tablets Market Drivers

12.2 Bicalutamide Tablets Market Restraints

12.3 Bicalutamide Tablets Trends Analysis

12.4 Porters Five Forces Analysis

12.4.1 Threat of New Entrants

12.4.2 Bargaining Power of Suppliers

12.4.3 Bargaining Power of Buyers

12.4.4 Threat of Substitutes

12.4.5 Competitive Rivalry

12.5 Influence of COVID-19 and Russia-Ukraine War

12.5.1 Influence of COVID-19

12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

13.1 Raw Material of Bicalutamide Tablets and Key Manufacturers

13.2 Manufacturing Costs Percentage of Bicalutamide Tablets

13.3 Bicalutamide Tablets Production Process

13.4 Bicalutamide Tablets Industrial Chain

14 Shipments by Distribution Channel

14.1 Sales Channel

14.1.1 Direct to End-User

14.1.2 Distributors

14.2 Bicalutamide Tablets Typical Distributors

14.3 Bicalutamide Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Research Process and Data Source

16.3 Disclaimer

List of Tables

Table 1. Global Bicalutamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Bicalutamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors

Table 4. AstraZeneca Major Business

Table 5. AstraZeneca Bicalutamide Tablets Product and Services

Table 6. AstraZeneca Bicalutamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 7. AstraZeneca Recent Developments/Updates

Table 8. Fosun Pharma Basic Information, Manufacturing Base and Competitors

Table 9. Fosun Pharma Major Business

Table 10. Fosun Pharma Bicalutamide Tablets Product and Services

Table 11. Fosun Pharma Bicalutamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 12. Fosun Pharma Recent Developments/Updates

Table 13. HISUN Basic Information, Manufacturing Base and Competitors

Table 14. HISUN Major Business

Table 15. HISUN Bicalutamide Tablets Product and Services

Table 16. HISUN Bicalutamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 17. HISUN Recent Developments/Updates

Table 18. FORWARD Basic Information, Manufacturing Base and Competitors

Table 19. FORWARD Major Business

Table 20. FORWARD Bicalutamide Tablets Product and Services

Table 21. FORWARD Bicalutamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 22. FORWARD Recent Developments/Updates

Table 23. CordenPharma Basic Information, Manufacturing Base and Competitors

Table 24. CordenPharma Major Business

Table 25. CordenPharma Bicalutamide Tablets Product and Services

Table 26. CordenPharma Bicalutamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 27. CordenPharma Recent Developments/Updates

Table 28. Global Bicalutamide Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)

Table 29. Global Bicalutamide Tablets Revenue by Manufacturer (2018-2023) & (USD Million)

Table 30. Global Bicalutamide Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)

Table 31. Market Position of Manufacturers in Bicalutamide Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022

Table 32. Head Office and Bicalutamide Tablets Production Site of Key Manufacturer

Table 33. Bicalutamide Tablets Market: Company Product Type Footprint

Table 34. Bicalutamide Tablets Market: Company Product Application Footprint

Table 35. Bicalutamide Tablets New Market Entrants and Barriers to Market Entry

Table 36. Bicalutamide Tablets Mergers, Acquisition, Agreements, and Collaborations

Table 37. Global Bicalutamide Tablets Sales Quantity by Region (2018-2023) & (K Units)

Table 38. Global Bicalutamide Tablets Sales Quantity by Region (2024-2029) & (K Units)

Table 39. Global Bicalutamide Tablets Consumption Value by Region (2018-2023) & (USD Million)

Table 40. Global Bicalutamide Tablets Consumption Value by Region (2024-2029) & (USD Million)

Table 41. Global Bicalutamide Tablets Average Price by Region (2018-2023) & (US$/Unit)

Table 42. Global Bicalutamide Tablets Average Price by Region (2024-2029) & (US$/Unit)

Table 43. Global Bicalutamide Tablets Sales Quantity by Type (2018-2023) & (K Units)

Table 44. Global Bicalutamide Tablets Sales Quantity by Type (2024-2029) & (K Units)

Table 45. Global Bicalutamide Tablets Consumption Value by Type (2018-2023) & (USD Million)

Table 46. Global Bicalutamide Tablets Consumption Value by Type (2024-2029) & (USD Million)

Table 47. Global Bicalutamide Tablets Average Price by Type (2018-2023) & (US$/Unit)

Table 48. Global Bicalutamide Tablets Average Price by Type (2024-2029) & (US$/Unit)

Table 49. Global Bicalutamide Tablets Sales Quantity by Application (2018-2023) & (K Units)

Table 50. Global Bicalutamide Tablets Sales Quantity by Application (2024-2029) & (K Units)

Table 51. Global Bicalutamide Tablets Consumption Value by Application (2018-2023) & (USD Million)

Table 52. Global Bicalutamide Tablets Consumption Value by Application (2024-2029) & (USD Million)

Table 53. Global Bicalutamide Tablets Average Price by Application (2018-2023) & (US$/Unit)

Table 54. Global Bicalutamide Tablets Average Price by Application (2024-2029) & (US$/Unit)

Table 55. North America Bicalutamide Tablets Sales Quantity by Type (2018-2023) & (K Units)

Table 56. North America Bicalutamide Tablets Sales Quantity by Type (2024-2029) & (K Units)

Table 57. North America Bicalutamide Tablets Sales Quantity by Application (2018-2023) & (K Units)

Table 58. North America Bicalutamide Tablets Sales Quantity by Application (2024-2029) & (K Units)

Table 59. North America Bicalutamide Tablets Sales Quantity by Country (2018-2023) & (K Units)

Table 60. North America Bicalutamide Tablets Sales Quantity by Country (2024-2029) & (K Units)

Table 61. North America Bicalutamide Tablets Consumption Value by Country (2018-2023) & (USD Million)

Table 62. North America Bicalutamide Tablets Consumption Value by Country (2024-2029) & (USD Million)

Table 63. Europe Bicalutamide Tablets Sales Quantity by Type (2018-2023) & (K Units)

Table 64. Europe Bicalutamide Tablets Sales Quantity by Type (2024-2029) & (K Units)

Table 65. Europe Bicalutamide Tablets Sales Quantity by Application (2018-2023) & (K Units)

Table 66. Europe Bicalutamide Tablets Sales Quantity by Application (2024-2029) & (K Units)

Table 67. Europe Bicalutamide Tablets Sales Quantity by Country (2018-2023) & (K Units)

Table 68. Europe Bicalutamide Tablets Sales Quantity by Country (2024-2029) & (K Units)

Table 69. Europe Bicalutamide Tablets Consumption Value by Country (2018-2023) & (USD Million)

Table 70. Europe Bicalutamide Tablets Consumption Value by Country (2024-2029) & (USD Million)

Table 71. Asia-Pacific Bicalutamide Tablets Sales Quantity by Type (2018-2023) & (K Units)

Table 72. Asia-Pacific Bicalutamide Tablets Sales Quantity by Type (2024-2029) & (K Units)

Table 73. Asia-Pacific Bicalutamide Tablets Sales Quantity by Application (2018-2023) & (K Units)

Table 74. Asia-Pacific Bicalutamide Tablets Sales Quantity by Application (2024-2029) & (K Units)

Table 75. Asia-Pacific Bicalutamide Tablets Sales Quantity by Region (2018-2023) & (K Units)

Table 76. Asia-Pacific Bicalutamide Tablets Sales Quantity by Region (2024-2029) & (K Units)

Table 77. Asia-Pacific Bicalutamide Tablets Consumption Value by Region (2018-2023) & (USD Million)

Table 78. Asia-Pacific Bicalutamide Tablets Consumption Value by Region (2024-2029) & (USD Million)

Table 79. South America Bicalutamide Tablets Sales Quantity by Type (2018-2023) & (K Units)

Table 80. South America Bicalutamide Tablets Sales Quantity by Type (2024-2029) & (K Units)

Table 81. South America Bicalutamide Tablets Sales Quantity by Application (2018-2023) & (K Units)

Table 82. South America Bicalutamide Tablets Sales Quantity by Application (2024-2029) & (K Units)

Table 83. South America Bicalutamide Tablets Sales Quantity by Country (2018-2023) & (K Units)

Table 84. South America Bicalutamide Tablets Sales Quantity by Country (2024-2029) & (K Units)

Table 85. South America Bicalutamide Tablets Consumption Value by Country (2018-2023) & (USD Million)

Table 86. South America Bicalutamide Tablets Consumption Value by Country (2024-2029) & (USD Million)

Table 87. Middle East & Africa Bicalutamide Tablets Sales Quantity by Type (2018-2023) & (K Units)

Table 88. Middle East & Africa Bicalutamide Tablets Sales Quantity by Type (2024-2029) & (K Units)

Table 89. Middle East & Africa Bicalutamide Tablets Sales Quantity by Application (2018-2023) & (K Units)

Table 90. Middle East & Africa Bicalutamide Tablets Sales Quantity by Application (2024-2029) & (K Units)

Table 91. Middle East & Africa Bicalutamide Tablets Sales Quantity by Region (2018-2023) & (K Units)

Table 92. Middle East & Africa Bicalutamide Tablets Sales Quantity by Region (2024-2029) & (K Units)

Table 93. Middle East & Africa Bicalutamide Tablets Consumption Value by Region (2018-2023) & (USD Million)

Table 94. Middle East & Africa Bicalutamide Tablets Consumption Value by Region (2024-2029) & (USD Million)

Table 95. Bicalutamide Tablets Raw Material

Table 96. Key Manufacturers of Bicalutamide Tablets Raw Materials

Table 97. Bicalutamide Tablets Typical Distributors

Table 98. Bicalutamide Tablets Typical Customers

List of Figures

Figure 1. Bicalutamide Tablets Picture

Figure 2. Global Bicalutamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Bicalutamide Tablets Consumption Value Market Share by Type in 2022

Figure 4. 14 Tablets Per Box Examples

Figure 5. 28 Tablets Per Box Examples

Figure 6. Global Bicalutamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Figure 7. Global Bicalutamide Tablets Consumption Value Market Share by Application in 2022

Figure 8. Hospital Examples

Figure 9. Clinic Examples

Figure 10. Global Bicalutamide Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 11. Global Bicalutamide Tablets Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 12. Global Bicalutamide Tablets Sales Quantity (2018-2029) & (K Units)

Figure 13. Global Bicalutamide Tablets Average Price (2018-2029) & (US$/Unit)

Figure 14. Global Bicalutamide Tablets Sales Quantity Market Share by Manufacturer in 2022

Figure 15. Global Bicalutamide Tablets Consumption Value Market Share by Manufacturer in 2022

Figure 16. Producer Shipments of Bicalutamide Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021

Figure 17. Top 3 Bicalutamide Tablets Manufacturer (Consumption Value) Market Share in 2022

Figure 18. Top 6 Bicalutamide Tablets Manufacturer (Consumption Value) Market Share in 2022

Figure 19. Global Bicalutamide Tablets Sales Quantity Market Share by Region (2018-2029)

Figure 20. Global Bicalutamide Tablets Consumption Value Market Share by Region (2018-2029)

Figure 21. North America Bicalutamide Tablets Consumption Value (2018-2029) & (USD Million)

Figure 22. Europe Bicalutamide Tablets Consumption Value (2018-2029) & (USD Million)

Figure 23. Asia-Pacific Bicalutamide Tablets Consumption Value (2018-2029) & (USD Million)

Figure 24. South America Bicalutamide Tablets Consumption Value (2018-2029) & (USD Million)

Figure 25. Middle East & Africa Bicalutamide Tablets Consumption Value (2018-2029) & (USD Million)

Figure 26. Global Bicalutamide Tablets Sales Quantity Market Share by Type (2018-2029)

Figure 27. Global Bicalutamide Tablets Consumption Value Market Share by Type (2018-2029)

Figure 28. Global Bicalutamide Tablets Average Price by Type (2018-2029) & (US$/Unit)

Figure 29. Global Bicalutamide Tablets Sales Quantity Market Share by Application (2018-2029)

Figure 30. Global Bicalutamide Tablets Consumption Value Market Share by Application (2018-2029)

Figure 31. Global Bicalutamide Tablets Average Price by Application (2018-2029) & (US$/Unit)

Figure 32. North America Bicalutamide Tablets Sales Quantity Market Share by Type (2018-2029)

Figure 33. North America Bicalutamide Tablets Sales Quantity Market Share by Application (2018-2029)

Figure 34. North America Bicalutamide Tablets Sales Quantity Market Share by Country (2018-2029)

Figure 35. North America Bicalutamide Tablets Consumption Value Market Share by Country (2018-2029)

Figure 36. United States Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 37. Canada Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 38. Mexico Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 39. Europe Bicalutamide Tablets Sales Quantity Market Share by Type (2018-2029)

Figure 40. Europe Bicalutamide Tablets Sales Quantity Market Share by Application (2018-2029)

Figure 41. Europe Bicalutamide Tablets Sales Quantity Market Share by Country (2018-2029)

Figure 42. Europe Bicalutamide Tablets Consumption Value Market Share by Country (2018-2029)

Figure 43. Germany Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 44. France Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 45. United Kingdom Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 46. Russia Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 47. Italy Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 48. Asia-Pacific Bicalutamide Tablets Sales Quantity Market Share by Type (2018-2029)

Figure 49. Asia-Pacific Bicalutamide Tablets Sales Quantity Market Share by Application (2018-2029)

Figure 50. Asia-Pacific Bicalutamide Tablets Sales Quantity Market Share by Region (2018-2029)

Figure 51. Asia-Pacific Bicalutamide Tablets Consumption Value Market Share by Region (2018-2029)

Figure 52. China Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 53. Japan Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 54. Korea Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 55. India Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 56. Southeast Asia Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 57. Australia Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 58. South America Bicalutamide Tablets Sales Quantity Market Share by Type (2018-2029)

Figure 59. South America Bicalutamide Tablets Sales Quantity Market Share by Application (2018-2029)

Figure 60. South America Bicalutamide Tablets Sales Quantity Market Share by Country (2018-2029)

Figure 61. South America Bicalutamide Tablets Consumption Value Market Share by Country (2018-2029)

Figure 62. Brazil Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 63. Argentina Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 64. Middle East & Africa Bicalutamide Tablets Sales Quantity Market Share by Type (2018-2029)

Figure 65. Middle East & Africa Bicalutamide Tablets Sales Quantity Market Share by Application (2018-2029)

Figure 66. Middle East & Africa Bicalutamide Tablets Sales Quantity Market Share by Region (2018-2029)

Figure 67. Middle East & Africa Bicalutamide Tablets Consumption Value Market Share by Region (2018-2029)

Figure 68. Turkey Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 69. Egypt Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 70. Saudi Arabia Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 71. South Africa Bicalutamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 72. Bicalutamide Tablets Market Drivers

Figure 73. Bicalutamide Tablets Market Restraints

Figure 74. Bicalutamide Tablets Market Trends

Figure 75. Porters Five Forces Analysis

Figure 76. Manufacturing Cost Structure Analysis of Bicalutamide Tablets in 2022

Figure 77. Manufacturing Process Analysis of Bicalutamide Tablets

Figure 78. Bicalutamide Tablets Industrial Chain

Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors

Figure 80. Direct Channel Pros & Cons

Figure 81. Indirect Channel Pros & Cons

Figure 82. Methodology

Figure 83. Research Process and Data Source